Stay updated on Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.

Latest updates to the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page
- Check4 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a page update. This change does not modify the study details or displayed information.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedTwo new locations were added: Yamaguchi University Hospital in Yamaguchi, Japan, and IRCCS Istituto Clinico Humanitas in Rozzano, Italy, bringing the total number of sites to 92.SummaryDifference0.3%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision marker was updated from v3.6.2 to v3.6.3, signaling a new version of the page.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a small platform update to the page rendering.SummaryDifference0.0%

- Check61 days agoChange DetectedNew and updated study locations were added (e.g., Taichung Veterans General Hospital in Taichung, Taiwan; Nanfang Hospital, Southern Medical University; Guangzhou, Guangdong, China 510515), and the total number of locations changed from 88 to 90. The page now includes additional navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates to the Intervention/Treatment header.SummaryDifference0.5%

- Check69 days agoChange DetectedA new revision entry labeled Revision: v3.5.5 with dates 2026-06-03 and 2026-06-02 was added to the page. The previous revision entry Revision: v3.5.4 with dates 2026-05-28 and 2026-05-27 appears to have been removed.SummaryDifference0.1%

Stay in the know with updates to Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.